BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1884116)

  • 1. Kinetics of (+)-tubocurarine blockade at the neuromuscular junction.
    Le Dain AC; Madsen BW; Edeson RO
    Br J Pharmacol; 1991 Jun; 103(2):1607-13. PubMed ID: 1884116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.
    Rang HP; Rylett RJ
    Br J Pharmacol; 1984 Mar; 81(3):519-31. PubMed ID: 6141831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule.
    Shaker N; Eldefrawi AT; Aguayo LG; Warnick JE; Albuquerque EX; Eldefrawi ME
    J Pharmacol Exp Ther; 1982 Jan; 220(1):172-7. PubMed ID: 6273528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actions of tubocurarine at the frog neuromuscular junction.
    Colquhoun D; Dreyer F; Sheridan RE
    J Physiol; 1979 Aug; 293():247-84. PubMed ID: 315462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An attempt to distinguish between the actions of neuromuscular blocking drugs on the acetylcholine receptor and on its associated ionic channel.
    Lambert JJ; Volle RL; Henderson EG
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):5003-7. PubMed ID: 6254051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural visualization of the transmembranous and cytomatrix-related part of nicotinic acetylcholine receptor of frog motor endplate by means of an immunochemical avidity of IgG for d-tubocurarine.
    Hirai K; Katayama Y; Peltre G; Tsuji S
    Folia Histochem Cytobiol; 2008; 46(1):111-6. PubMed ID: 18296273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of local anaesthetic alteration of miniature end-plate currents and end-plate current fluctuations.
    Ruff RL
    J Physiol; 1977 Jan; 264(1):89-124. PubMed ID: 190384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine.
    Bufler J; Wilhelm R; Parnas H; Franke C; Dudel J
    J Physiol; 1996 Aug; 495 ( Pt 1)(Pt 1):83-95. PubMed ID: 8866353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsynaptic effects of ethanol at the frog neuromuscular junction.
    Bradley RJ; Peper K; Sterz R
    Nature; 1980 Mar; 284(5751):60-2. PubMed ID: 6965526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necessity of divalent cations for recovery from carbachol-induced nicotinic acetylcholine receptor inactivation at snake twitch fibre endplates.
    Hardwick JC; Parsons RL
    Br J Pharmacol; 1993 Oct; 110(2):889-95. PubMed ID: 7694760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.
    Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX
    Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of the presynaptic effects of (+)-tubocurarine at the mouse neuromuscular junction.
    Ferry CB; Kelly SS
    J Physiol; 1988 Sep; 403():425-37. PubMed ID: 3253424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of tubocurarine on nicotinic cholinoreceptors of neurons of the sympathetic ganglia of rats].
    Selianko AA; Derkach VA; Kurennyĭ DE; Skok VI
    Neirofiziologiia; 1988; 20(5):672-80. PubMed ID: 3211232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of the synergistic interactions between organic calcium channel antagonists and various neuromuscular blocking agents.
    Chang CC; Chiou LC; Hwang LL; Huang CY
    Jpn J Pharmacol; 1990 Jul; 53(3):285-92. PubMed ID: 2167989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinetics of tubocurarine action and restricted diffusion within the synaptic cleft.
    Armstrong DL; Lester HA
    J Physiol; 1979 Sep; 294():365-86. PubMed ID: 229214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive block and ion channel block as mechanisms of antagonist action on the skeletal muscle end-plate.
    Colquhoun D
    Adv Biochem Psychopharmacol; 1980; 21():67-80. PubMed ID: 6246760
    [No Abstract]   [Full Text] [Related]  

  • 18. The decay of end-plate currents in neostigmine-treated frog muscle blocked by acetylcholine or tubocurarine.
    Guinan JJ
    J Physiol; 1980 Aug; 305():345-55. PubMed ID: 6969307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-competitive effects of disopyramide at the neuromuscular junction: evidence for endplate ion channel block.
    Jones SV; Marshall IG
    Br J Anaesth; 1987 Jun; 59(6):776-83. PubMed ID: 2440467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of miniature endplate potential frequency by acetylcholine and its analogues in frog.
    Nikolsky EE; Bukharaeva EA; Strunsky EG; Vyskocil F
    Br J Pharmacol; 1991 Dec; 104(4):1024-32. PubMed ID: 1667283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.